Who is sponsoring NCT05909631?

NCT05909631 is sponsored by Sulaimani Polytechnic University.

What drugs are being tested in NCT05909631?

Interventions in NCT05909631: Beetroot juice, placebo, Mediterranean diet alone (MeD), Mediterranean diet with beet juice (BJ+MeD).

What condition does NCT05909631 study?

NCT05909631 studies NAFLD, Non-alcoholic Fatty Liver Disease.

Is NCT05909631 still recruiting?

NCT05909631 is currently completed. Last updated 18 June 2023.

Last reviewed 2023-06-18 · How we verify

NCT05909631: BJ

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparing Effects of Beetroot Juice and Mediterranean Diet on Liver Enzymes and Sonography in Patients With NAFLD

Completed Phase 1 Last updated 18 June 2023

What this trial tests

Phase 1 trial testing Beetroot juice in NAFLD, Non-alcoholic Fatty Liver Disease in 180 participants. Completed in 11 April 2023.

Timeline

10 January 2023

Primary endpoint
20 February 2023

11 April 2023

Quick facts

Lead sponsor	Sulaimani Polytechnic University
Phase	Phase 1
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	treatment
Enrollment	180
Start date	10 January 2023
Primary completion	20 February 2023
Estimated completion	11 April 2023
Sites	1 location across Iraq

Drugs / interventions tested

Beetroot juice — full drug profile →
placebo
Mediterranean diet alone (MeD)
Mediterranean diet with beet juice (BJ+MeD)

Conditions studied

NAFLD, Non-alcoholic Fatty Liver Disease — all drugs for NAFLD, Non-alcoholic Fatty Liver Disease →

Sponsor

Sulaimani Polytechnic University

Who can join

Adults 19 to 73, any sex, with NAFLD, Non-alcoholic Fatty Liver Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial study is to investigate comparing Effects of Beetroot juice and Mediterranean diet on Liver Enzymes and Sonographic appearance in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) The main question\[s\] it aims to answer are: 1. Beetroot juice has role in reduce Liver Enzymes 2. Mediterranean diet has role in reduce Liver Enzymes

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Comparing effects of beetroot juice and Mediterranean diet on liver enzymes and sonographic appearance in patients with non-alcoholic fatty liver disease: a randomized control trials.
Fateh HL, Rashid SA, Muhammad SS, Al-Jaf SH, et al · · 2023 · cited 6× · PMID 37662597 · DOI 10.3389/fnut.2023.1181706

Verify or expand the search:

Other trials of Beetroot juice

Trials testing the same drug.

NCT06598488 — Beetroot Juice: A Natural Boost for Cardiovascular Health in Postmenopausal Women? · NA · completed
NCT06695429 — Supplementation With Beetroot Juice to Prevent Contrast Associated Nephropathy During Hospitalization for Acute Coronary · NA · recruiting
NCT06286748 — Beetroot Extract Supplementation Associated With an Exercise Protocol for Chronic Kidney Disease Patients · NA · recruiting
NCT06416228 — Beetroot Juice NO Cold Study · Phase 2 · recruiting
NCT06227091 — The Effect od Beetroot Juice on Forearm Muscle Strength and Muscle EMG Activity After BloodFlow Restriction · NA · enrolling by invitation

Other Sulaimani Polytechnic University trials

Trials by the same sponsor.

NCT07038135 — Formulation, Phytochemical Characterization, and Clinical Assessment of a Novel Natural Supplement Targeting Body Compos · NA · completed
NCT05897606 — Effect of Multi Vitamin and Mineral Supplementation of Liver Enzymes and Sonography in Patient With NAFLD · Phase 1 · completed
NCT05851313 — Role of Vit-D Supplementation on BioNTech, Pfizer Vaccine Side Effect and Immunoglobulin G Response · Phase 3 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05909631 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sulaimani Polytechnic University
Last refreshed: 18 June 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05909631.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing